About
Myopharm is a pioneering Australian biopharmacetical company focused on clinically validated innovations for diabetes, chronic inflammation and weight loss.
Headquartered in Sydney Australia, Myopharm has a deep pipeline of pharmaceutical and nutritional innovations. All Myopharm products are manufactured in a Good Manufacturing Practice(GMP) accredited site. Myopharm reinvests 10% of all gross profit back into in-house diabetes research and development.
Our products
Myopharm has a range of clinically validated consumer health products for diabetes and wellness. Myopharm strives to enhance & prolong lives in those with metabolic and inflammatory diseases.
